Cytokinetics Vs. Nukkleus Industry Stock Comparison

Sell

21

CYTK
Cytokinetics

Last Price:

$46.37

Seasonality Move:

-1.45%

Sell

23

NUKK
Nukkleus

Last Price:

$19.11

Seasonality Move:

48.46%

Sell

21

Cytokinetics (CYTK) is a Sell

Is Cytokinetics a Buy, Sell or Hold?

The current Cytokinetics [CYTK] share price is $47.37. The Score for CYTK is 21, which is 58% below its historic median score of 50, and infers higher risk than normal.
CYTK is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

Sell

23

Nukkleus (NUKK) is a Sell

Is Nukkleus a Buy, Sell or Hold?

The current Nukkleus [NUKK] share price is $21.00. The Score for NUKK is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.
NUKK is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

CYTK Stock Price Chart

What is Cytokinetics's stock price today?

The Cytokinetics share price today is $47.37

Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CYTK is experiencing selling pressure, which indicates risk of future bearish movement.

NUKK Stock Price Chart

What is Nukkleus's stock price today?

The Nukkleus share price today is $21.00

The current trend is moderately bearish and NUKK is experiencing slight selling pressure.

CYTK Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	-0.72	Sell
Relative Strength Index (14 RSI):	41.28	Sell
Chaikin Money Flow:	-616553	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(47.53 - 50.37)	Sell
Bollinger Bands (100):	(49.73 - 55.87)	Sell

NUKK Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	5.09	Buy
Relative Strength Index (14 RSI):	48.74	Sell
Chaikin Money Flow:	-90986	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(3.08 - 39.18)	Sell
Bollinger Bands (100):	(-5.25 - 19.13)	Buy

CYTK Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	48.11	Sell
20-day SMA:	48.5	Sell
50-day SMA:	50.75	Sell
200-day SMA:	56.16	Sell
8-day EMA:	48.27	Sell
20-day EMA:	48.75	Sell
50-day EMA:	50.34	Sell
200-day EMA:	53.74	Sell

NUKK Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	30	Sell
20-day SMA:	26.02	Sell
50-day SMA:	11.64	Buy
200-day SMA:	6.16	Buy
8-day EMA:	27.7	Sell
20-day EMA:	25.09	Sell
50-day EMA:	16.11	Buy
200-day EMA:	13.92	Buy

Cytokinetics Earnings Growth & CYTK Earnings Dates

Analysts estimate an earnings decrease this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and an increase next year of $1.29 per share.

Nukkleus Earnings Growth & NUKK Earnings Dates

Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Cytokinetics Technical Analysis

	Dec 24	Dec 26	Dec 27	Dec 30	Dec 31	Jan 2	Jan 3	Jan 6	Jan 7	Jan 8
	Dec						Jan
	24	26	27	30	31	02	03	06	07	08
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Nukkleus Technical Analysis

	Dec 24	Dec 26	Dec 27	Dec 30	Dec 31	Jan 2	Jan 3	Jan 6	Jan 7	Jan 8
	Dec						Jan
	24	26	27	30	31	02	03	06	07	08
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):